Your browser doesn't support javascript.
loading
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Daver, Naval; Kantarjian, Hagop; Garcia-Manero, Guillermo; Jabbour, Elias; Borthakur, Gautam; Brandt, Mark; Pierce, Sherry; Vaughan, Kenneth; Ning, Jing; Nogueras González, Graciela M; Patel, Keyur; Jorgensen, Jeffery; Pemmaraju, Naveen; Kadia, Tapan; Konopleva, Marina; Andreeff, Michael; DiNardo, Courtney; Cortes, Jorge; Ward, Renee; Craig, Adam; Ravandi, Farhad.
Afiliação
  • Daver N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA ndaver@mdanderson.org fravandi@mdanderson.org.
  • Kantarjian H; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Brandt M; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Pierce S; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Vaughan K; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Ning J; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Nogueras González GM; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Patel K; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Jorgensen J; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Kadia T; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Andreeff M; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • DiNardo C; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Cortes J; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Ward R; Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA.
  • Craig A; Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA.
  • Ravandi F; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA ndaver@mdanderson.org fravandi@mdanderson.org.
Haematologica ; 102(10): 1709-1717, 2017 10.
Article em En | MEDLINE | ID: mdl-28729302
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article